Raja Manchanda has served as a Partner at Sagard and a member of the Sagard Healthcare team since 2018. Raja is responsible for overseeing Sagard’s healthcare strategy to invest in approved and commercialized biopharmaceuticals, diagnostics, and medical devices that are protected by strong intellectual property. Alongside David MacNaughtan and Ali Alagheband, he co-leads the Sagard Healthcare team in their management of the investment process, including origination, due diligence, execution, and portfolio management. Raja is a member of the Sagard Healthcare investment committee and is based in Toronto, Canada. Raja has known David for over a decade and worked with him at DRI Capital for 2 years. He has known Ali and worked with him at DRI Capital for over a decade.
Prior to Sagard, Raja was a Vice President at DRI Capital, focused on sourcing royalty monetization investment opportunities from the academic and corporate sectors. Raja has over 15 years of healthcare investing experience focused on investment banking, public equities and royalty-based opportunities.
Raja holds an HBA from the Richard Ivey School of Business at the University of Western Ontario, where he graduated with Distinction, and a Master of Finance from Queen’s University.
